Mesoblast Ltd SEC filings MESO
Mesoblast Ltd has 598 filings in SEC EDGAR's recent list, going back to Nov 8, 2005. Its latest annual report, Form 20-F, was filed on Aug 27, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Nov 2, 2026 |
| 6-K | Current report (foreign issuer) | Oct 29, 2026 | Oct 29, 2026 |
| 6-K | Current report (foreign issuer) | Oct 16, 2026 | Oct 16, 2026 |
| 6-K | Current report (foreign issuer) | Oct 15, 2026 | Oct 14, 2026 |
| 6-K | Current report (foreign issuer) | Oct 13, 2026 | Oct 13, 2026 |
| 6-K | Current report (foreign issuer) | Sep 24, 2026 | Sep 24, 2026 |
| 6-K | Current report (foreign issuer) | Aug 27, 2026 | Aug 27, 2026 |
| 20-F | Annual report (foreign issuer) | Aug 27, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Aug 25, 2026 | Aug 25, 2026 |
| 6-K | Current report (foreign issuer) | Aug 24, 2026 | Aug 24, 2026 |
| 6-K | Current report (foreign issuer) | Aug 18, 2026 | Aug 17, 2026 |
| 6-K | Current report (foreign issuer) | Jul 30, 2026 | Jul 30, 2026 |
| 6-K | Current report (foreign issuer) | Jul 21, 2026 | Jul 21, 2026 |
| 6-K | Current report (foreign issuer) | Jul 15, 2026 | Jul 14, 2026 |
| 6-K | Current report (foreign issuer) | Jul 14, 2026 | Jul 14, 2026 |
| 6-K | Current report (foreign issuer) | Jul 10, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 9, 2026 | Jul 7, 2026 |
| 6-K | Current report (foreign issuer) | Jul 1, 2026 | Jul 1, 2026 |
| 6-K | Current report (foreign issuer) | Jun 25, 2026 | Jun 25, 2026 |
| 6-K | Current report (foreign issuer) | Jun 10, 2026 | Jun 10, 2026 |
| 6-K | Current report (foreign issuer) | Apr 30, 2026 | Apr 30, 2026 |
| 3 | Initial insider ownership | Apr 29, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Apr 29, 2026 | Apr 29, 2026 |
| 6-K | Current report (foreign issuer) | Apr 17, 2026 | Apr 17, 2026 |
| 6-K | Current report (foreign issuer) | Apr 15, 2026 | Apr 15, 2026 |
| 4 | Insider transaction | Apr 13, 2026 | Apr 9, 2026 |
| 4 | Insider transaction | Apr 10, 2026 | Apr 9, 2026 |
| 6-K | Current report (foreign issuer) | Apr 8, 2026 | Apr 8, 2026 |
| 6-K | Current report (foreign issuer) | Apr 8, 2026 | Apr 8, 2026 |
| 6-K | Current report (foreign issuer) | Apr 8, 2026 | Apr 8, 2026 |
| 6-K | Current report (foreign issuer) | Apr 8, 2026 | Apr 8, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 23, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Mar 23, 2026 | Mar 23, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 16, 2026 | Mar 16, 2026 |
| 6-K | Current report (foreign issuer) | Mar 13, 2026 | Mar 12, 2026 |
| 6-K | Current report (foreign issuer) | Mar 12, 2026 | Mar 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 11, 2026 | — |
| 6-K | Current report (foreign issuer) | Feb 27, 2026 | Feb 27, 2026 |
| 6-K | Current report (foreign issuer) | Feb 27, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Feb 23, 2026 | Feb 23, 2026 |
| 6-K | Current report (foreign issuer) | Feb 12, 2026 | Feb 12, 2026 |
| 6-K | Current report (foreign issuer) | Jan 29, 2026 | Jan 29, 2026 |
| 6-K | Current report (foreign issuer) | Jan 28, 2026 | Jan 28, 2026 |
| 6-K | Current report (foreign issuer) | Jan 21, 2026 | Jan 19, 2026 |
| 6-K | Current report (foreign issuer) | Jan 16, 2026 | Jan 16, 2026 |
| EFFECT | Filing | Jan 14, 2026 | — |
| 424B3 | Prospectus | Jan 14, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 14, 2026 | Jan 14, 2026 |
| 6-K | Current report (foreign issuer) | Jan 13, 2026 | Jan 12, 2026 |
| CORRESP | Letter to the SEC | Jan 12, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 9, 2026 | Jan 9, 2026 |
| 6-K | Current report (foreign issuer) | Jan 7, 2026 | Jan 7, 2026 |
| UPLOAD | Letter from the SEC | Jan 5, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 2, 2026 | Jan 2, 2026 |
| F-3ASR | Registration statement | Dec 31, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 30, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 30, 2025 | Dec 30, 2025 |
| 6-K | Current report (foreign issuer) | Dec 29, 2025 | Dec 24, 2025 |
| 6-K | Current report (foreign issuer) | Dec 18, 2025 | Dec 17, 2025 |
| 6-K | Current report (foreign issuer) | Dec 12, 2025 | Dec 12, 2025 |
| 6-K | Current report (foreign issuer) | Dec 4, 2025 | Dec 4, 2025 |
| 6-K | Current report (foreign issuer) | Nov 26, 2025 | Nov 25, 2025 |
| 6-K | Current report (foreign issuer) | Nov 25, 2025 | Nov 25, 2025 |
| 6-K | Current report (foreign issuer) | Nov 24, 2025 | Nov 21, 2025 |
| 6-K | Current report (foreign issuer) | Nov 17, 2025 | Nov 17, 2025 |
| 6-K | Current report (foreign issuer) | Nov 5, 2025 | Nov 5, 2025 |
| 6-K | Current report (foreign issuer) | Oct 29, 2025 | Oct 29, 2025 |
| 6-K | Current report (foreign issuer) | Oct 28, 2025 | Oct 28, 2025 |
| 6-K | Current report (foreign issuer) | Oct 22, 2025 | Oct 22, 2025 |
| 6-K | Current report (foreign issuer) | Oct 15, 2025 | Oct 15, 2025 |
| 6-K | Current report (foreign issuer) | Oct 7, 2025 | Oct 7, 2025 |
| 6-K | Current report (foreign issuer) | Oct 3, 2025 | Oct 3, 2025 |
| 6-K | Current report (foreign issuer) | Sep 29, 2025 | Sep 29, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 16, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 15, 2025 | Sep 15, 2025 |
| 6-K | Current report (foreign issuer) | Sep 15, 2025 | Sep 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Sep 12, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 4, 2025 | Sep 4, 2025 |
| 6-K | Current report (foreign issuer) | Aug 29, 2025 | Aug 29, 2025 |
| 20-F | Annual report (foreign issuer) | Aug 29, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Aug 27, 2025 | Aug 27, 2025 |
| 6-K | Current report (foreign issuer) | Jul 18, 2025 | Jul 18, 2025 |
| 6-K | Current report (foreign issuer) | Jul 15, 2025 | Jul 15, 2025 |
| 6-K | Current report (foreign issuer) | Jul 1, 2025 | Jul 1, 2025 |
| 6-K | Current report (foreign issuer) | Jun 12, 2025 | Jun 12, 2025 |
| 6-K | Current report (foreign issuer) | May 15, 2025 | May 15, 2025 |
| 6-K | Current report (foreign issuer) | Apr 30, 2025 | Apr 30, 2025 |
| 6-K | Current report (foreign issuer) | Apr 29, 2025 | Apr 29, 2025 |
| 6-K | Current report (foreign issuer) | Apr 24, 2025 | Apr 24, 2025 |
| 6-K | Current report (foreign issuer) | Apr 17, 2025 | Apr 17, 2025 |
| 6-K | Current report (foreign issuer) | Apr 15, 2025 | Apr 14, 2025 |
| 6-K | Current report (foreign issuer) | Apr 9, 2025 | Apr 8, 2025 |
| 6-K | Current report (foreign issuer) | Apr 4, 2025 | Apr 4, 2025 |
| 6-K | Current report (foreign issuer) | Apr 3, 2025 | Apr 3, 2025 |
| 6-K | Current report (foreign issuer) | Mar 31, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 27, 2025 | Mar 27, 2025 |
| 6-K | Current report (foreign issuer) | Mar 14, 2025 | Mar 14, 2025 |
| 6-K | Current report (foreign issuer) | Mar 13, 2025 | Mar 13, 2025 |
| 6-K | Current report (foreign issuer) | Mar 12, 2025 | Mar 12, 2025 |
| 6-K | Current report (foreign issuer) | Mar 7, 2025 | Mar 7, 2025 |
| 6-K | Current report (foreign issuer) | Feb 28, 2025 | Feb 27, 2025 |
| 6-K | Current report (foreign issuer) | Feb 27, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Feb 25, 2025 | Feb 24, 2025 |
| 6-K | Current report (foreign issuer) | Feb 14, 2025 | Feb 14, 2025 |
| EFFECT | Filing | Feb 12, 2025 | — |
| 424B3 | Prospectus | Feb 12, 2025 | — |
| CORRESP | Letter to the SEC | Feb 10, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2025 | — |
| F-3/A | Amendment no. 1 to form f-3 | Feb 6, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Feb 5, 2025 | — |
| 6-K | Current report (foreign issuer) | Jan 31, 2025 | Jan 31, 2025 |
| 6-K | Current report (foreign issuer) | Jan 24, 2025 | Jan 24, 2025 |
| 6-K | Current report (foreign issuer) | Jan 16, 2025 | Jan 14, 2025 |
| EFFECT | Filing | Dec 27, 2024 | — |
| 424B3 | Prospectus | Dec 27, 2024 | — |
| CORRESP | Letter to the SEC | Dec 23, 2024 | — |
| F-3/A | Amendment no. 1 to form f-3 | Dec 23, 2024 | — |
| 6-K | Current report (foreign issuer) | Dec 23, 2024 | Dec 23, 2024 |
| 6-K | Current report (foreign issuer) | Dec 20, 2024 | Dec 19, 2024 |
| 6-K | Current report (foreign issuer) | Dec 20, 2024 | Dec 18, 2024 |
| UPLOAD | Letter from the SEC | Dec 18, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Dec 16, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 13, 2024 | — |
| 6-K | Current report (foreign issuer) | Dec 9, 2024 | Dec 9, 2024 |
| 6-K | Current report (foreign issuer) | Dec 4, 2024 | Dec 3, 2024 |
| 6-K | Current report (foreign issuer) | Nov 18, 2024 | Nov 18, 2024 |
| 6-K | Current report (foreign issuer) | Nov 13, 2024 | Nov 13, 2024 |
| 6-K | Current report (foreign issuer) | Nov 1, 2024 | Oct 31, 2024 |
| 6-K | Current report (foreign issuer) | Oct 18, 2024 | Oct 17, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 9, 2024 | — |
| 6-K | Current report (foreign issuer) | Oct 1, 2024 | Oct 1, 2024 |
| 6-K | Current report (foreign issuer) | Aug 29, 2024 | Aug 29, 2024 |
| 20-F | Annual report (foreign issuer) | Aug 29, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | Aug 1, 2024 | Jul 31, 2024 |
| 6-K | Current report (foreign issuer) | Jul 25, 2024 | Jul 23, 2024 |
| 6-K | Current report (foreign issuer) | Jul 23, 2024 | Jul 22, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 11, 2024 | — |
| 6-K | Current report (foreign issuer) | Jul 10, 2024 | Jul 9, 2024 |
| 6-K | Current report (foreign issuer) | Jul 2, 2024 | Jul 1, 2024 |
| 6-K | Current report (foreign issuer) | Jun 4, 2024 | Jun 4, 2024 |
| 6-K | Current report (foreign issuer) | May 10, 2024 | May 10, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | May 3, 2024 | — |
| 6-K | Current report (foreign issuer) | May 3, 2024 | May 3, 2024 |
| 6-K | Current report (foreign issuer) | May 1, 2024 | Apr 30, 2024 |
| 424B3 | Prospectus | Apr 26, 2024 | — |
| EFFECT | Filing | Apr 24, 2024 | — |
| CORRESP | Letter to the SEC | Apr 22, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 19, 2024 | — |
| 6-K | Current report (foreign issuer) | Apr 17, 2024 | Apr 16, 2024 |
| 6-K | Current report (foreign issuer) | Apr 17, 2024 | Apr 16, 2024 |
| 6-K | Current report (foreign issuer) | Apr 17, 2024 | Apr 16, 2024 |
| 6-K | Current report (foreign issuer) | Apr 17, 2024 | Apr 16, 2024 |
| F-3 | Shelf registration (foreign issuer) | Apr 16, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 9, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 3, 2024 | — |
| 6-K | Current report (foreign issuer) | Mar 27, 2024 | Mar 26, 2024 |
| 6-K | Current report (foreign issuer) | Mar 21, 2024 | Mar 20, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 20, 2024 | — |
| 6-K | Current report (foreign issuer) | Mar 15, 2024 | Mar 14, 2024 |
| 6-K | Current report (foreign issuer) | Mar 12, 2024 | Mar 12, 2024 |
| 6-K | Current report (foreign issuer) | Mar 1, 2024 | Feb 29, 2024 |
| 6-K | Current report (foreign issuer) | Feb 29, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Feb 21, 2024 | Feb 15, 2024 |
| 6-K | Current report (foreign issuer) | Feb 1, 2024 | Jan 31, 2024 |
| 6-K | Current report (foreign issuer) | Jan 23, 2024 | Jan 19, 2024 |
| 6-K | Current report (foreign issuer) | Jan 16, 2024 | Jan 16, 2024 |
| F-6 POS | Filing | Jan 5, 2024 | — |
| 6-K | Current report (foreign issuer) | Jan 5, 2024 | Jan 5, 2024 |
| 6-K | Current report (foreign issuer) | Jan 5, 2024 | Jan 4, 2024 |
| F-6 POS | Filing | Dec 22, 2023 | — |
| F-6 POS | Filing | Dec 22, 2023 | — |
| F-6 POS | Filing | Dec 21, 2023 | — |
| 6-K | Current report (foreign issuer) | Nov 29, 2023 | Nov 29, 2023 |
| 6-K | Current report (foreign issuer) | Nov 24, 2023 | Nov 22, 2023 |
| 6-K | Current report (foreign issuer) | Nov 1, 2023 | Oct 31, 2023 |
| 6-K | Current report (foreign issuer) | Oct 30, 2023 | Oct 30, 2023 |
| 6-K | Current report (foreign issuer) | Oct 18, 2023 | Oct 17, 2023 |
| 6-K | Current report (foreign issuer) | Oct 3, 2023 | Oct 2, 2023 |
| 6-K | Current report (foreign issuer) | Sep 26, 2023 | Sep 26, 2023 |
| 6-K | Current report (foreign issuer) | Sep 25, 2023 | Sep 21, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Sep 6, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Sep 6, 2023 | — |
| 6-K | Current report (foreign issuer) | Aug 31, 2023 | Aug 31, 2023 |
| 20-F | Annual report (foreign issuer) | Aug 31, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Aug 4, 2023 | Aug 4, 2023 |
| 6-K | Current report (foreign issuer) | Aug 1, 2023 | Aug 1, 2023 |
| F-6EF | Filing | Jul 31, 2023 | — |
| 6-K | Current report (foreign issuer) | Jul 31, 2023 | Jul 31, 2023 |
| 6-K | Current report (foreign issuer) | Jul 12, 2023 | Jul 11, 2023 |
| 6-K | Current report (foreign issuer) | Jun 13, 2023 | Jun 13, 2023 |
| 6-K | Current report (foreign issuer) | Jun 6, 2023 | Jun 5, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- MESO (Nasdaq), MEOBF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Melbourne, Victoria, Australia
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1345099
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.